Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genotoxic effects of occupational exposure to glass fibres - A human biomonitoring study.
Ceppi M, Smolkova B, Staruchova M, Kazimirova A, Barancokova M, Volkovova K, Collins A, Kocan A, Dzupinkova Z, Horska A, Buocikova V, Tulinska J, Liskova A, Mikusova ML, Krivosikova Z, Wsolova L, Kuba D, Rundén-Pran E, El Yamani N, Longhin EM, Halašová E, Kyrtopoulos S, Bonassi S, Dusinska M. Ceppi M, et al. Among authors: buocikova v. Mutat Res Genet Toxicol Environ Mutagen. 2023 Jan;885:503572. doi: 10.1016/j.mrgentox.2022.503572. Epub 2022 Nov 30. Mutat Res Genet Toxicol Environ Mutagen. 2023. PMID: 36669817 Free article.
Genetic determinants of quantitative traits associated with cardiovascular disease risk.
Smolková B, Bonassi S, Buociková V, Dušinská M, Horská A, Kuba D, Džupinková Z, Rašlová K, Gašparovič J, Slíž I, Ceppi M, Vohnout B, Wsólová L, Volkovová K. Smolková B, et al. Among authors: buocikova v. Mutat Res. 2015 Aug;778:18-25. doi: 10.1016/j.mrfmmm.2015.05.005. Epub 2015 May 15. Mutat Res. 2015. PMID: 26043189
Impact of interleukin 13 (IL13) genetic polymorphism Arg130Gln on total serum immunoglobulin (IgE) levels and interferon (IFN)-γ gene expression.
Smolkova B, Tulinska J, Palkovicova Murinova L, Buocikova V, Liskova A, Rausova K, Kuricova M, Patayova H, Sustrova M, Neubauerova Svorcova E, Ilavska S, Szabova M, Nemessanyi T, Jahnova E, Dusinska M, Ciznar P, Fuortes L. Smolkova B, et al. Among authors: buocikova v. Clin Exp Immunol. 2017 Apr;188(1):45-52. doi: 10.1111/cei.12923. Epub 2017 Feb 7. Clin Exp Immunol. 2017. PMID: 28054352 Free PMC article.
Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives.
Buocikova V, Rios-Mondragon I, Pilalis E, Chatziioannou A, Miklikova S, Mego M, Pajuste K, Rucins M, Yamani NE, Longhin EM, Sobolev A, Freixanet M, Puntes V, Plotniece A, Dusinska M, Cimpan MR, Gabelova A, Smolkova B. Buocikova V, et al. Cancers (Basel). 2020 Dec 3;12(12):3622. doi: 10.3390/cancers12123622. Cancers (Basel). 2020. PMID: 33287297 Free PMC article. Review.
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Buocikova V, Longhin EM, Pilalis E, Mastrokalou C, Miklikova S, Cihova M, Poturnayova A, Mackova K, Babelova A, Trnkova L, El Yamani N, Zheng C, Rios-Mondragon I, Labudova M, Csaderova L, Kuracinova KM, Makovicky P, Kucerova L, Matuskova M, Cimpan MR, Dusinska M, Babal P, Chatziioannou A, Gabelova A, Rundén-Pran E, Smolkova B. Buocikova V, et al. Biomed Pharmacother. 2022 Mar;147:112662. doi: 10.1016/j.biopha.2022.112662. Epub 2022 Jan 25. Biomed Pharmacother. 2022. PMID: 35091237 Free article.
Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression.
Buocikova V, Tyciakova S, Pilalis E, Mastrokalou C, Urbanova M, Matuskova M, Demkova L, Medova V, Longhin EM, Rundén-Pran E, Dusinska M, Rios-Mondragon I, Cimpan MR, Gabelova A, Soltysova A, Smolkova B, Chatziioannou A. Buocikova V, et al. Front Pharmacol. 2022 Oct 5;13:991751. doi: 10.3389/fphar.2022.991751. eCollection 2022. Front Pharmacol. 2022. PMID: 36278182 Free PMC article.
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
Urbanova M, Cihova M, Buocikova V, Slopovsky J, Dubovan P, Pindak D, Tomas M, García-Bermejo L, Rodríguez-Garrote M, Earl J, Kohl Y, Kataki A, Dusinska M, Sainz B Jr, Smolkova B, Gabelova A. Urbanova M, et al. Among authors: buocikova v. Biomed Pharmacother. 2023 Sep;165:115179. doi: 10.1016/j.biopha.2023.115179. Epub 2023 Jul 21. Biomed Pharmacother. 2023. PMID: 37481927 Free article. Review.
Uncovering accurate prognostic markers for high-risk uveal melanoma through DNA methylation profiling.
Soltysova A, Dvorska D, Kajabova VH, Pecimonova M, Cepcekova K, Ficek A, Demkova L, Buocikova V, Babal P, Juras I, Janikova K, Kasubova I, Samec M, Brany D, Lyskova D, Valaskova J, Dankova Z, Smolkova B, Furdova A. Soltysova A, et al. Among authors: buocikova v. Clin Transl Med. 2023 Jul;13(7):e1317. doi: 10.1002/ctm2.1317. Clin Transl Med. 2023. PMID: 37478301 Free PMC article. No abstract available.
A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.
Zmetakova I, Kalinkova L, Smolkova B, Horvathova Kajabova V, Cierna Z, Danihel L, Bohac M, Sedlackova T, Minarik G, Karaba M, Benca J, Cihova M, Buocikova V, Miklikova S, Mego M, Fridrichova I. Zmetakova I, et al. Among authors: buocikova v. Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18. Cancer Sci. 2019. PMID: 30815959 Free PMC article.
Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells.
Schmidtova S, Kalavska K, Gercakova K, Cierna Z, Miklikova S, Smolkova B, Buocikova V, Miskovska V, Durinikova E, Burikova M, Chovanec M, Matuskova M, Mego M, Kucerova L. Schmidtova S, et al. Among authors: buocikova v. Cancers (Basel). 2019 Aug 22;11(9):1224. doi: 10.3390/cancers11091224. Cancers (Basel). 2019. PMID: 31443351 Free PMC article.
15 results